Botulinum neurotoxin A mutants with enhanced ganglioside binding show improved potency and altered ganglioside selectivity
Abstract Botulinum neurotoxins are the causative agents of botulism, a lethal paralytic disease, but are also one of the most commonly used therapeutics for the treatment of numerous neuromuscular conditions. These toxins recognise motor nerve terminals with high specificity and affinity by using a...
Saved in:
| Main Authors: | Geoffrey Masuyer, Andreas Rummel, Pål Stenmark |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-06-01
|
| Series: | Communications Chemistry |
| Online Access: | https://doi.org/10.1038/s42004-025-01569-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gangliosides in milk
by: Slavica Potočki, et al.
Published: (2016-07-01) -
Insights into Siglec‐7 Binding to Gangliosides: NMR Protein Assignment and the Impact of Ligand Flexibility
by: Cristina Di Carluccio, et al.
Published: (2025-06-01) -
Altered expression of genes involved in ganglioside biosynthesis in substantia nigra neurons in Parkinson's disease.
by: Jay S Schneider
Published: (2018-01-01) -
Comprehensive Modular Synthesis of Ganglioside Glycans and Evaluation of their Binding Affinities to Siglec‐7 and Siglec‐9
by: Avijit K. Adak, et al.
Published: (2025-01-01) -
Targeting O-Acetyl-GD2 Ganglioside for Cancer Immunotherapy
by: Julien Fleurence, et al.
Published: (2017-01-01)